Home 2023

AMGen

BMS Expands Its Cancer Portfolio with Up-to-$5.8B Mirati Purchase
Cancer

BMS Expands Its Cancer Portfolio with Up-to-$5.8B Mirati Purchase

Alex Philippidis -
0
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Drug Discovery

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb

Alex Philippidis -
0
Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Alex Philippidis -
0
Top 10 U.S. Biopharma Clusters
A-Lists

Top 10 U.S. Biopharma Clusters

Alex Philippidis -
0
Alliance for Genomic Discovery Announces Five Founding Biopharma Members
Industry News

Alliance for Genomic Discovery Announces Five Founding Biopharma Members

Julianna LeMieux, PhD -
0
As Patent Cliff Looms for Biopharma Giants, Smaller Biotechs Face Cash Crunch
Bioprocessing

As Patent Cliff Looms for Biopharma Giants, Smaller Biotechs Face Cash Crunch

Alex Philippidis -
22
StockWatch: FTC vs. Amgen-Horizon Could Slam Brakes on Biotech M&A
Drug Discovery

StockWatch: FTC vs. Amgen-Horizon Could Slam Brakes on Biotech M&A

Alex Philippidis -
18
Amgen Vows to Fight Back as FTC Takes Aim at $27.8B Horizon Deal
Drug Discovery

Amgen Vows to Fight Back as FTC Takes Aim at $27.8B Horizon Deal

Alex Philippidis -
28
Top 25 Biotech Companies of 2023
A-Lists

Top 25 Biotech Companies of 2023

Alex Philippidis -
20
Big Pharma Leadership Decries the Inflation Reduction Act
Artificial Intelligence

Big Pharma Leadership Decries the Inflation Reduction Act

Jonathan D Grinstein, PhD -
0
123...29Page 1 of 29
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.